Furthermore, the expression level of ELAVL2 was low in gliomas with wild-type isocitrate dehydrogenase 1 (IDH1) gene (Fig. 2e), which plays a critical role in glioma progression1. This evidence concerns the gene ELAVL2 and central nervous system cancer.